Florian Deuschl
Overview
Explore the profile of Florian Deuschl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chadderdon S, Eleid M, Thaden J, Makkar R, Nakamura M, Babaliaros V, et al.
Struct Heart
. 2023 Jun;
6(4):100071.
PMID: 37288338
Patients with severe symptomatic tricuspid regurgitation face a significant dilemma in treatment options, as the yearly mortality with medical therapy and the surgical mortality for tricuspid repair or replacement are...
2.
Nikolayevska O, Conradi L, Schirmer J, Reichenspurner H, Deuschl F, Blankenberg S, et al.
Clin Res Cardiol
. 2023 Apr;
113(1):18-28.
PMID: 37017780
Aims: This study was performed to compare haemodynamic properties of a novel transcatheter heart valve (THV) with two established valve technologies for treatment of failing surgical aortic bioprosthetic valves (SAV)....
3.
Davidson C, Abramson S, Smith R, Kodali S, Kipperman R, Eleid M, et al.
JACC Cardiovasc Imaging
. 2021 Mar;
15(3):533-538.
PMID: 33744150
No abstract available.
4.
Muntane-Carol G, Taramasso M, Miura M, Gavazzoni M, Pozzoli A, Alessandrini H, et al.
Circ Cardiovasc Interv
. 2021 Feb;
14(2):e009685.
PMID: 33541097
Background: Scarce data exist on patients with right ventricular dysfunction (RVD) or pulmonary hypertension (PH) undergoing transcatheter tricuspid valve intervention. This study aimed to determine the early and midterm outcomes...
5.
Kodali S, Hahn R, Eleid M, Kipperman R, Smith R, Lim D, et al.
J Am Coll Cardiol
. 2021 Jan;
77(4):345-356.
PMID: 33509390
Background: Tricuspid regurgitation (TR) is a prevalent disease with limited treatment options. Objectives: This is the first 30-day report of the U.S. single-arm, multicenter, prospective CLASP TR early feasibility study...
6.
Davidson C, Lim D, Smith R, Kodali S, Kipperman R, Eleid M, et al.
JACC Cardiovasc Interv
. 2021 Jan;
14(1):41-50.
PMID: 33413863
Objectives: The study reports for the first time the 30-day outcomes of the first U.S. study with the Cardioband tricuspid valve reconstruction system for the treatment of functional tricuspid regurgitation...
7.
Nickenig G, Weber M, Schuler R, Hausleiter J, Nabauer M, von Bardeleben R, et al.
EuroIntervention
. 2020 Oct;
16(15):e1264-e1271.
PMID: 33046437
Aims: Tricuspid regurgitation (TR) is associated with high morbidity and mortality rates with limited treatment options. We report one- and two-year outcomes of the Cardioband tricuspid valve reconstruction system in...
8.
Miura M, Alessandrini H, Alkhodair A, Attinger-Toller A, Biasco L, Lurz P, et al.
JACC Cardiovasc Interv
. 2020 Sep;
13(17):1999-2009.
PMID: 32912460
Objectives: The aim of this study was to assess the clinical outcome of baseline massive or torrential tricuspid regurgitation (TR) after transcatheter tricuspid valve intervention (TTVI). Background: The use of...
9.
Yoon S, Kim W, Dhoble A, Pio S, Babaliaros V, Jilaihawi H, et al.
J Am Coll Cardiol
. 2020 Aug;
76(9):1018-1030.
PMID: 32854836
Background: Bicuspid aortic stenosis accounts for almost 50% of patients undergoing surgical aortic valve replacement in the younger patients. Expanding the indication of transcatheter aortic valve replacement (TAVR) toward lower-risk...
10.
Ludwig S, Gossling A, Waldschmidt L, Linder M, Bhadra O, Voigtlander L, et al.
Am Heart J
. 2020 Jun;
225:138-148.
PMID: 32502877
Background: Compared to high gradient aortic stenosis (AS), patients with low-flow, low-gradient AS have higher mortality after transcatheter aortic valve replacement (TAVR), but distinct outcome predictors in this patient subset...